ABRAM’S CLINICAL DRUG THERAPY
a a a
RATIONALES FOR
a a
NURSING PRACTICE 13TH EDITION
a a a
aGERALYN FRANDSEN’S a
aTESTBANK/COMPLETE GUIDE 2024- a a
2025/ALL CHAPTERS 1-61
a a
,
,Chapter 1: The Foundation of Pharmacology: Quality and Safety
a a a a a a a a
1. A apatient adiagnosed awith aobsessive–compulsive adisorder ahas abeen
aprescribed aorala paroxetine ahydrochloride. aWhat a is athe aexpected aeffect
a for athis aprescription?
A. Curative aeffect aon asymptoms
B. Systemic aeffect aon asymptoms
C. Local aeffect aon asymptoms
D. Parenteral aeffect a on asymptoms
ACCURATE aANSWER:-B
REASONING:->>>Pharmaceutical adrug athat aproduce asystemic aeffects aare ataken
ainto athe abody, acirculated athrough athe abloodstream ato atheir asites aof aaction ain
avarious abody atissues, aand aeventually aeliminated afrom athe abody. aCurative
aagents aare agiven ato acure aa adisease aprocess. aInathis acase, aparoxetine
ahydrochloride awill acontrol athe asymptoms abut anot acure athe adisorder.
Pharmaceutical adrug awith alocal aeffects, asuch aas asunscreen aand alocal aanesthetics,
aact a mainly aat athe asite aof aapplication. aParoxetine ahydrochloride ais anot
aadministered aparenterally. aParenteral aagents aare aadministered asubcutaneously,
a intramuscularly, a or aintravenously.
POINTS: 1 REFERENCE: p. a3, aIntroduction OBJ: 1
NAT: aHospital aclient aNeeds: aPhysiological aIntegrity: aPharmacological aand
aParenteral aTherapiesa TOP: Chapter: a1: aThe aFoundation aof aPharmacology:
aQuality aand aSafety
KEY: a Integrated aProcess: aNursing aProcess
BLM: a Cognitive aLevel: aUnderstand NOT: a Multiple aChoice
2. A ahospital aclient ahas abeen aprescribed aan aantibiotic. aThis apharmaceutical
adrug ais aa anaturally aoccurring asubstance athat ahas abeen
ache m ic al ly mod if ied. WhaOt a aMi as a aanother aname afor athis a type aof
G R A D E S B OO S T .C
apharmaceutical adrug?
A. Synthetic adrug
B. Semisynthetic adrug
C. Biotechnology adrug
D. Prototype adrug
ACCURATE aANSWER:-B
REASONING:->>>Semisynthetic apharmaceutical adrug a(e.g., amany aantibiotics)
aare anaturally aoccurring asubstances athat ahave abeen achemically amodified.
aSynthetic apharmaceutical adrug aare amore astandardized ain atheir achemical
acharacteristics, amore aconsistent ain atheir aeffects, aand aless alikely ato aproduce
aallergic areactions. aBiotechnology apharmaceutical adrug ainvolve amanipulating
aDNAa and aRNA aand arecombining agenes ainto ahybrid amolecules athat acan abe
ainserted ainto aliving aorganisms. aPrototype a pharmaceutical adrug aare athe a first
a drug aof aa aparticular agroup ato abe adeveloped.
POINTS: 1 REFERENCE: p. a3, aDrug aSources OBJ:
1
NAT: aHospital aclient aNeeds: aPhysiological aIntegrity: aPharmacological aand
aParenteral aTherapiesa TOP: Chapter: a1: aThe aFoundation aof aPharmacology:
aQuality aand aSafety
KEY: a Integrated aProcess: aNursing aProcess
BLM: a Cognitive aLevel: aUnderstand NOT: a Multiple aChoice
, 3. Which aclassification aapplies ato amorphine?
A. Central anervous asystem adepressant
B. Central anervous asystem astimulant
a a a
RATIONALES FOR
a a
NURSING PRACTICE 13TH EDITION
a a a
aGERALYN FRANDSEN’S a
aTESTBANK/COMPLETE GUIDE 2024- a a
2025/ALL CHAPTERS 1-61
a a
,
,Chapter 1: The Foundation of Pharmacology: Quality and Safety
a a a a a a a a
1. A apatient adiagnosed awith aobsessive–compulsive adisorder ahas abeen
aprescribed aorala paroxetine ahydrochloride. aWhat a is athe aexpected aeffect
a for athis aprescription?
A. Curative aeffect aon asymptoms
B. Systemic aeffect aon asymptoms
C. Local aeffect aon asymptoms
D. Parenteral aeffect a on asymptoms
ACCURATE aANSWER:-B
REASONING:->>>Pharmaceutical adrug athat aproduce asystemic aeffects aare ataken
ainto athe abody, acirculated athrough athe abloodstream ato atheir asites aof aaction ain
avarious abody atissues, aand aeventually aeliminated afrom athe abody. aCurative
aagents aare agiven ato acure aa adisease aprocess. aInathis acase, aparoxetine
ahydrochloride awill acontrol athe asymptoms abut anot acure athe adisorder.
Pharmaceutical adrug awith alocal aeffects, asuch aas asunscreen aand alocal aanesthetics,
aact a mainly aat athe asite aof aapplication. aParoxetine ahydrochloride ais anot
aadministered aparenterally. aParenteral aagents aare aadministered asubcutaneously,
a intramuscularly, a or aintravenously.
POINTS: 1 REFERENCE: p. a3, aIntroduction OBJ: 1
NAT: aHospital aclient aNeeds: aPhysiological aIntegrity: aPharmacological aand
aParenteral aTherapiesa TOP: Chapter: a1: aThe aFoundation aof aPharmacology:
aQuality aand aSafety
KEY: a Integrated aProcess: aNursing aProcess
BLM: a Cognitive aLevel: aUnderstand NOT: a Multiple aChoice
2. A ahospital aclient ahas abeen aprescribed aan aantibiotic. aThis apharmaceutical
adrug ais aa anaturally aoccurring asubstance athat ahas abeen
ache m ic al ly mod if ied. WhaOt a aMi as a aanother aname afor athis a type aof
G R A D E S B OO S T .C
apharmaceutical adrug?
A. Synthetic adrug
B. Semisynthetic adrug
C. Biotechnology adrug
D. Prototype adrug
ACCURATE aANSWER:-B
REASONING:->>>Semisynthetic apharmaceutical adrug a(e.g., amany aantibiotics)
aare anaturally aoccurring asubstances athat ahave abeen achemically amodified.
aSynthetic apharmaceutical adrug aare amore astandardized ain atheir achemical
acharacteristics, amore aconsistent ain atheir aeffects, aand aless alikely ato aproduce
aallergic areactions. aBiotechnology apharmaceutical adrug ainvolve amanipulating
aDNAa and aRNA aand arecombining agenes ainto ahybrid amolecules athat acan abe
ainserted ainto aliving aorganisms. aPrototype a pharmaceutical adrug aare athe a first
a drug aof aa aparticular agroup ato abe adeveloped.
POINTS: 1 REFERENCE: p. a3, aDrug aSources OBJ:
1
NAT: aHospital aclient aNeeds: aPhysiological aIntegrity: aPharmacological aand
aParenteral aTherapiesa TOP: Chapter: a1: aThe aFoundation aof aPharmacology:
aQuality aand aSafety
KEY: a Integrated aProcess: aNursing aProcess
BLM: a Cognitive aLevel: aUnderstand NOT: a Multiple aChoice
, 3. Which aclassification aapplies ato amorphine?
A. Central anervous asystem adepressant
B. Central anervous asystem astimulant
